By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



115 avenue Lacassagne

Lyon    69003  France
Phone: +33-(0)4-72-610-610 Fax: +33-(0)4-72-363-967




Company News
Adocia And Eli Lilly (LLY) Initiate New Phase 1b Study Of Repeated Administration Of Ultra-Rapid Biochaperone Lispro In Patients With Type 1 Diabetes 8/27/2015 9:53:50 AM
Adocia Presents Financial Results For The First Half Of 2015 Highlighting Strong Growth 7/21/2015 2:07:27 PM
Adocia Initiates Two Clinical Studies On Its Combination Of Long-Acting Insulin Glargine And Fast-Acting Insulin Lispro, Biochaperone Combo 7/10/2015 1:58:14 PM
Adocia And Eli Lilly (LLY) Report Positive Phase 1b Topline Results On The Post-Meal Effect Of Ultra-Rapid Biochaperone Lispro In Patients With Type 1 Diabetes 6/29/2015 12:10:30 PM
Adocia Is Now Integrated Into The CAC Mid 60 And SBF 120 Indices 6/15/2015 1:15:59 PM
Adocia To Present Positive Clinical Results For BioChaperone Lispro At The American Diabetes Association 75th Scientific Sessions On June 6th 2015 5/28/2015 12:15:27 PM
Adocia To Present At The Jefferies and Co. 2015 Global Healthcare Conference In New-York City (USA) 5/26/2015 10:58:45 AM
Adocia Announces First Quarter 2015 Results 4/14/2015 12:05:23 PM
Adocia Opens A Subsidiary In The USA And Is Pleased To Appoint Simon Bruce, MD And Stephen Daly 3/5/2015 10:53:37 AM
Adocia: Annual Revenue And Net Cash Position For 2014 2/17/2015 10:59:45 AM